期刊文献+

晚期大肠癌应用FOLFOX4方案治疗的临床疗效观察 被引量:4

晚期大肠癌应用FOLFOX4方案治疗的临床疗效观察
下载PDF
导出
摘要 目的评价和探讨FOLFOX4方案治疗晚期大肠癌的疗效和不良反应。方法 2007年3月~2000年2月对12例接受治疗的晚期大肠癌患者采用FOLFOX4方案化疗(奥沙利铂+亚叶酸钙+5-氟尿嘧啶)。第1天,静脉滴入奥沙利铂80mg/m2小时;第1、2天,静脉滴入亚叶酸钙180mg/m2小时,5-氟尿嘧啶450mg/m2推注后静脉滴入650mg/m2持续22小时。每2周重复一次,4周为1周期。结果全组12例患者均可评价疗效及不良反应。经过治疗,患者完全缓解2例,部分缓解4例,稳定3例,总有效率50%。毒副反应主要为消化道反应和神经毒性,以I~Ⅱ度为主。结论 FOLFOX4方案治疗晚期大肠癌疗效明显,安全性较高,初治患者效果更佳。 Objective To observe and evaluate the effects and toxicity of FOLFOX4 regimen in treating patients with advanced colorectal carcinoma.Methods 12 cases of patients with advanced colorectal cancer in our hospital for treatment from January 2007 to April 2008 were treated with FOLFOX4 re men(Oxaliplatin+CF+5-Fu).80 mg/m2 of infusion were carried on intravenous perfusion for 2 hours in first day;180mg/m2 m of CF were carried on intravenous perfusion for 2 hours,then 450 mg/m2 of 5-Fu were carried on intravenous perfusion and then 650 mg/m2 continuing for 22 hours in first and second day.Above-mentioned treatment were repeated every two weeks,four weeks was for a cycle.Results 12 cases were eligible for efficacy and toxicity evaluation.the Clinical treatment effects were following:complete response in 2 cases,partial response in 4 cases,stable disease in 3 cases.and the total response rate was 50%.The main toxicity was gastrointestinal reaction and neurotoxicity,by grade I or Ⅱ for primarily.Conclusion FOLFOX4 regimen for advanced colorectal cancer is effective and safety in colorectal carcinoma.So it is better fit for the patients of initial Treatment
作者 江国洪
出处 《当代医学》 2011年第36期125-126,共2页 Contemporary Medicine
关键词 晚期大肠癌 FOLFOX4方案 临床疗效 Advanced colorectal cancer FOLFOX4 regimen Clinical treatment effects
  • 相关文献

参考文献5

二级参考文献29

  • 1张文,许立功.晚期结直肠癌的化疗进展[J].中国癌症杂志,2004,14(4):378-382. 被引量:25
  • 2陆仰东.国产奥沙利铂为主的联合化疗治疗51例晚期大肠癌疗效观察[J].中国肿瘤临床,2004,31(24):1401-1403. 被引量:5
  • 3李海金,董良,李英,符淑媛.FOLFOX4治疗52例晚期大肠癌[J].肿瘤学杂志,2007,13(2):108-110. 被引量:4
  • 4[3]Parkin DM,Bray F,Feday J,et al.Global cancer statistics,2002[J].CACancer J Clin,2005,55(2):74-108.
  • 5[4]Advanced Colorectal Cancer Meta-analysis Project.Modulmion of fluorouracil by Ieucovorin in patients with advanced colorectal cancer:evidence in terms of response rate[J].J Ciin Oncol,1992,10(6):896-903.
  • 6[5]Raymond E,Buquet FC.Antitumor activity of oxaliplatin in combination with 5-fluoronracil and the thymidylate synthase inhibitor AC337 in human colon,breast.and ovarian cancers[J].Anticancer Drugs,1997,8(1):87.
  • 7[6]Goldberg RM,Sargent DJ,Morton RF,et al.A randomized controlled trial of fluorouracil plus leucovorin,irinotecan,and oxaliplatin combinations in patients with previously untreated mntreated metastatic colorectal cancer[J]J Clin oncol,2004,22(1):22-30.
  • 8[7]De GA,Figer A,Seymour M,et al.Leueovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J].J Clin Oncol,2000,18(16):2937-2947.
  • 9Goldstein D, Mitchell P, Michal M, et al. Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer Patients[J]. Br J Cancer,2005, 92(5) :832-837.
  • 10Hsuen Lim E, Seng Cheong Lim R, Seng Wu T, et al. Oxaliplatin/fluorouracil/leucovorin in advanced colorectal carcinoma:an asian experience[J]. Pann Pharmacother,2003,37(12) :1909-1912.

共引文献43

同被引文献30

引证文献4

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部